MedPath

Preclinical and clinical evaluation of the siddha classical drug ATHIMADHURA KULIGAI(oral administration) along with KADUGU ENNAI (external application) in the management of AUTISM SPECTRUM DISORDER.

Phase 2
Completed
Conditions
Health Condition 1: F840- Autistic disorder
Registration Number
CTRI/2022/02/039889
Lead Sponsor
DrBTamil Elakkiya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1.Children have lack of eye contact

2.lack of response

3.Repeatative or restricted behaviour

4.Unawareness of natural urges

5.Acquired speech or lost it

6.Unusual senstivity to sensory stimuli

Exclusion Criteria

1.Children above 12 years

2.Children below 2 years

3.Seevere and recurrent seizures

4.ADHD

5.CP

6.Infantile hemiplegia

7.Congenital anomalies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath